DAFNA Capital Management

DAFNA Capital Management as of Dec. 31, 2022

Portfolio Holdings for DAFNA Capital Management

DAFNA Capital Management holds 79 positions in its portfolio as reported in the December 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spdr S&p Biotech Etf Etf (XBI) 13.2 $47M 566k 83.00
Stereotaxis Com New (STXS) 8.0 $28M 14M 2.07
Ascendis Pharma A/s Sponsored Adr (ASND) 4.5 $16M 130k 122.13
Karuna Therapeutics Ord 4.0 $14M 72k 196.50
Ishares Nasdaq Biotech Indx Etf (IBB) 3.8 $14M 103k 131.29
Iveric Bio 3.7 $13M 606k 21.41
Xenon Pharmaceuticals (XENE) 3.5 $13M 316k 39.43
Blueprint Medicines (BPMC) 3.2 $11M 261k 43.81
Revolution Medicines (RVMD) 3.2 $11M 478k 23.82
Syndax Pharmaceuticals (SNDX) 3.2 $11M 447k 25.45
Neurocrine Biosciences (NBIX) 2.5 $8.7M 73k 119.44
Ideaya Biosciences (IDYA) 2.4 $8.5M 468k 18.17
Cytokinetics Com New (CYTK) 2.4 $8.4M 184k 45.82
Dex (DXCM) 2.2 $7.6M 68k 113.24
Sage Therapeutics (SAGE) 1.9 $6.9M 180k 38.14
Edgewise Therapeutics (EWTX) 1.9 $6.9M 767k 8.94
Nurix Therapeutics (NRIX) 1.8 $6.2M 567k 10.98
Adicet Bio (ACET) 1.6 $5.6M 632k 8.94
Fate Therapeutics (FATE) 1.6 $5.6M 551k 10.09
Biohaven (BHVN) 1.5 $5.5M 393k 13.88
Morphic Hldg (MORF) 1.5 $5.2M 196k 26.75
Alector (ALEC) 1.4 $4.9M 532k 9.23
Viking Therapeutics (VKTX) 1.4 $4.9M 522k 9.40
Apellis Pharmaceuticals (APLS) 1.2 $4.3M 83k 51.71
Merus N V (MRUS) 1.2 $4.2M 270k 15.47
Kalvista Pharmaceuticals (KALV) 1.2 $4.2M 616k 6.76
89bio (ETNB) 1.2 $4.1M 324k 12.73
Cardiovascular Systems 1.1 $3.9M 287k 13.62
Dice Therapeutics 1.1 $3.9M 124k 31.20
F-star Therapeutics 1.0 $3.6M 577k 6.32
Bicycle Therapeutics Sponsored Ads (BCYC) 1.0 $3.6M 122k 29.60
Mirati Therapeutics 0.9 $3.3M 74k 45.31
Axogen (AXGN) 0.9 $3.3M 332k 9.98
AtriCure (ATRC) 0.9 $3.2M 72k 44.38
Compass Therapeutics (CMPX) 0.9 $3.0M 602k 5.03
Arcus Biosciences Incorporated (RCUS) 0.8 $2.9M 142k 20.68
BioCryst Pharmaceuticals (BCRX) 0.8 $2.9M 251k 11.48
Mediwound Shs New (MDWD) 0.8 $2.8M 204k 13.49
Accuray Incorporated (ARAY) 0.7 $2.6M 1.2M 2.09
Century Therapeutics (IPSC) 0.7 $2.4M 475k 5.13
Mersana Therapeutics (MRSN) 0.7 $2.4M 414k 5.86
Galapagos Nv Spon Adr (GLPG) 0.7 $2.3M 53k 44.38
Autolus Therapeutics Spon Ads (AUTL) 0.6 $2.2M 1.2M 1.90
Neuronetics (STIM) 0.6 $2.2M 314k 6.87
Vigil Neuroscience (VIGL) 0.6 $2.1M 169k 12.50
Larimar Therapeutics (LRMR) 0.6 $2.0M 473k 4.13
Iteos Therapeutics (ITOS) 0.5 $1.9M 99k 19.53
Kura Oncology (KURA) 0.5 $1.8M 145k 12.41
Keros Therapeutics (KROS) 0.4 $1.6M 33k 48.02
Oric Pharmaceuticals (ORIC) 0.4 $1.6M 264k 5.89
Cymabay Therapeutics 0.3 $1.1M 171k 6.27
Syros Pharmaceuticals Com New (SYRS) 0.3 $955k 266k 3.59
Genfit S A Ads (GNFT) 0.2 $869k 198k 4.39
Affimed Therapeutics B V 0.2 $851k 686k 1.24
Mereo Biopharma Group Spon Ads (MREO) 0.2 $822k 1.1M 0.75
Pardes Biosciences 0.2 $810k 479k 1.69
Regulus Therapeutics (RGLS) 0.2 $761k 556k 1.37
Karyopharm Therapeutics (KPTI) 0.2 $655k 193k 3.40
Surface Oncology 0.2 $642k 783k 0.82
Cincor Pharma 0.2 $590k 48k 12.29
Brainsway Sponsored Ads (BWAY) 0.2 $543k 220k 2.47
Adaptimmune Therapeutics Sponds Adr (ADAP) 0.1 $513k 351k 1.46
Masimo Corporation (MASI) 0.1 $444k 3.0k 147.95
Kinnate Biopharma (KNTE) 0.1 $433k 71k 6.10
Theseus Pharmaceuticals 0.1 $408k 82k 4.98
Ikena Oncology (IKNA) 0.1 $326k 123k 2.66
Medicenna Therapeutics Corp. (MDNAF) 0.1 $302k 660k 0.46
Inogen (INGN) 0.1 $296k 15k 19.71
Biomea Fusion (BMEA) 0.1 $292k 35k 8.43
Macrogenics (MGNX) 0.1 $268k 40k 6.71
Nextcure (NXTC) 0.1 $265k 188k 1.41
Scynexis Com New (SCYX) 0.1 $239k 153k 1.56
Spero Therapeutics (SPRO) 0.1 $216k 125k 1.73
Acrivon Therapeutics Common Stock (ACRV) 0.1 $180k 16k 11.52
Black Diamond Therapeutics (BDTX) 0.0 $176k 98k 1.80
Lineage Cell Therapeutics In (LCTX) 0.0 $164k 140k 1.17
Compugen Ord (CGEN) 0.0 $147k 205k 0.72
Reunion Neuroscience 0.0 $43k 48k 0.90
Phasebio Pharmaceuticals (PHASQ) 0.0 $9.7k 322k 0.03